Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-10

Clinical Trial Update: Promotion of Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in ICU Patients. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing promotion of oesophageal motility to prevent regurgitation and improve nutrition in critically ill patients with malnutrition; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: E-Motion Medical Ltd. | Conditions: Critically Ill, Malnutrition | Phase 2 | Status: COMPLETED